ArticleEndocrine, metabolic & immune disorders drug targets2026
Gut Microbiota, Lipidome, and Metabolites Mediate Immune Dysregulation in Diabetic Microvascular Disease: A Two-sample Mendelian Randomization and Mediation Analysis.
Jiaxing Zhao et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.